Teva Pharmaceutical Industries Ltd financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Industry
Pharmaceutical Preparations
Location
Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi'a St., Tel Aviv, Israel
State of incorporation
Israel
Fiscal year end
December 31
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (to 1/16/2001)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 98 % -7.72%
Quick Ratio 32.7 % -8.35%
Debt-to-equity 489 % +16%
Return On Equity -6.24 % +66.8%
Return On Assets -1.12 % +71.1%
Operating Margin 1.42 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.13B shares +1.09%
Entity Public Float 8.38B USD +14.8%
Common Stock, Value, Issued 58M USD +1.75%
Weighted Average Number of Shares Outstanding, Basic 1.12B shares +0.72%
Weighted Average Number of Shares Outstanding, Diluted 1.12B shares +0.72%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16B USD +7.23%
Research and Development Expense 98M USD
Selling and Marketing Expense 2.4B USD +7.68%
General and Administrative Expense 1.14B USD -3.05%
Operating Income (Loss) 228M USD -1577%
Nonoperating Income (Expense) -1.05B USD -8.16%
Income Tax Expense (Benefit) -40M USD +94%
Net Income (Loss) Attributable to Parent -478M USD +72.1%
Earnings Per Share, Basic -0.42 USD/shares +72.9%
Earnings Per Share, Diluted -0.42 USD/shares +72.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.99B USD +39.6%
Accounts Receivable, after Allowance for Credit Loss, Current 3.46B USD +0.61%
Inventory, Net 3.95B USD -4.1%
Other Assets, Current 495M USD -8.67%
Assets, Current 12.3B USD +6.92%
Deferred Income Tax Assets, Net 1.96B USD +24.3%
Property, Plant and Equipment, Net 5.62B USD -2.31%
Operating Lease, Right-of-Use Asset 364M USD -13.3%
Goodwill 17B USD -4.45%
Other Assets, Noncurrent 470M USD +4.44%
Assets 42.8B USD -1.58%
Employee-related Liabilities, Current 492M USD +13.9%
Liabilities, Current 13.8B USD +32.5%
Operating Lease, Liability, Noncurrent 294M USD -14.8%
Other Liabilities, Noncurrent 3.99B USD +0.23%
Liabilities 35.2B USD +0.78%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.78B USD -2.74%
Retained Earnings (Accumulated Deficit) -13.7B USD -3.63%
Stockholders' Equity Attributable to Parent 7.28B USD -7.41%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7.54B USD -11.3%
Liabilities and Equity 42.8B USD -1.58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.39B USD -7.03%
Net Cash Provided by (Used in) Financing Activities -1.36B USD +38.1%
Net Cash Provided by (Used in) Investing Activities 931M USD +37.7%
Common Stock, Shares Authorized 2.5B shares 0%
Common Stock, Shares, Issued 1.24B shares +0.98%
Common Stock, Par or Stated Value Per Share 0.1 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 815M USD +64.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.99B USD +37.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.08B USD +13.7%
Deferred Tax Assets, Valuation Allowance 3.01B USD -2.05%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.23 pure 0%
Deferred Tax Assets, Gross 1.81B USD +24.3%
Operating Lease, Liability 417M USD -5.66%
Depreciation 537M USD -6.77%
Payments to Acquire Property, Plant, and Equipment 119M USD -6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -548M USD +68.2%
Lessee, Operating Lease, Liability, to be Paid 496M USD -8.66%
Property, Plant and Equipment, Gross 11.4B USD +1.16%
Operating Lease, Liability, Current 320M USD -8.31%
Lessee, Operating Lease, Liability, to be Paid, Year Two 98M USD +4.26%
Lessee, Operating Lease, Liability, to be Paid, Year One 116M USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -340M USD +68.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 80M USD +1.27%
Current Income Tax Expense (Benefit) 333M USD -22.6%
Unrecognized Tax Benefits 651M USD +2.04%
Lessee, Operating Lease, Liability, to be Paid, Year Four 62M USD -6.06%
Operating Lease, Payments 141M USD +0.71%
Additional Paid in Capital 27.8B USD +0.28%
Amortization of Intangible Assets 603M USD -13.5%
Interest Expense 1.03B USD +10.6%